These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3498574)

  • 1. Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells.
    Walsh LJ; Lander PE; Seymour GJ; Powell RN
    Clin Exp Immunol; 1987 May; 68(2):366-74. PubMed ID: 3498574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gingival Langerhans cell T6 antigen expression in vitro by interleukin 1 and an interleukin 1 inhibitor.
    Walsh LJ; Seymour GJ; Powell RN
    Clin Exp Immunol; 1986 May; 64(2):334-41. PubMed ID: 3091301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of human B cell growth factor.
    Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
    J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and partial purification of a specific interleukin 2 inhibitor.
    Honda M; Chan C; Shevach EM
    J Immunol; 1985 Sep; 135(3):1834-9. PubMed ID: 3926886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
    Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
    Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of murine helper T cell-replacing factors.
    Watson J; Mochizuki D; Gillis S
    Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The purification and properties of human T cell growth factor.
    Mier JW; Gallo RC
    J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.
    Oppenheim JJ; Stadler BM; Siraganian RP; Mage M; Mathieson B
    Fed Proc; 1982 Feb; 41(2):257-62. PubMed ID: 6800841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 induces CD1 antigen expression on human gingival epithelial cells.
    Walsh LJ; Seymour GJ
    J Invest Dermatol; 1988 Jan; 90(1):13-6. PubMed ID: 3275721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the molecules.
    Montaldo PG; Lanciotti M; Castagnola E; Parodi MT; Cirillo C; Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1988; 7(4):413-27. PubMed ID: 3210814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.
    Mazzei GJ; Seckinger PL; Dayer JM; Shaw AR
    Eur J Immunol; 1990 Mar; 20(3):683-9. PubMed ID: 2138562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte chemotaxis in inflammation. VII. Isolation and purification of chemotactic factors for T lymphocytes from PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Hayashi H
    Immunology; 1984 Feb; 51(2):275-85. PubMed ID: 6607210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures for the purification of interleukin 3 to homogeneity.
    Ihle JN; Keller J; Henderson L; Klein F; Palaszynski E
    J Immunol; 1982 Dec; 129(6):2431-6. PubMed ID: 6815268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and physicochemical characterization of murine T cell replacing factor (TRF).
    Takatsu K; Harada N; Hara Y; Takahama Y; Yamada G; Dobashi K; Hamaoka T
    J Immunol; 1985 Jan; 134(1):382-9. PubMed ID: 3871109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.